These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7952800)

  • 21. Quinidine-enhanced beta-blockade during treatment with propafenone in extensive metabolizer human subjects.
    Mörike KE; Roden DM
    Clin Pharmacol Ther; 1994 Jan; 55(1):28-34. PubMed ID: 7905369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.
    Gex-Fabry M; Rudaz S; Balant-Gorgia AE; Brachet A; Veuthey JL; Balant LP; Bertschy G
    Eur J Clin Pharmacol; 2002 Aug; 58(5):323-31. PubMed ID: 12185556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias.
    Nielsen H; Sørum C; Rasmussen V; Madsen JK; Hansen JF
    Acta Cardiol; 1990; 45(5):359-63. PubMed ID: 1704168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
    Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective disposition and pharmacologic activity of propafenone enantiomers.
    Kroemer HK; Funck-Brentano C; Silberstein DJ; Wood AJ; Eichelbaum M; Woosley RL; Roden DM
    Circulation; 1989 May; 79(5):1068-76. PubMed ID: 2713973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients.
    Uehlinger C; Crettol S; Chassot P; Brocard M; Koeb L; Brawand-Amey M; Eap CB
    J Clin Psychopharmacol; 2007 Jun; 27(3):273-8. PubMed ID: 17502774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
    Aso R; Ohashi K; Katoh T; Ogata H
    Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A reversed phase HPLC method with pre-column derivatization to determine propafenone enantiomers in human plasma].
    Wang Y; Zhong D; Chen R
    Yao Xue Xue Bao; 1998; 33(2):138-42. PubMed ID: 11938950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
    Mondillo S; Faglia S; D'Aprile N; Mangiacotti L; Campolo MA; Agricola E; Palazzuoli V
    Clin Ter; 1995 Dec; 146(12):769-74. PubMed ID: 8681496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effects of propafenone in the treatment of ventricular arrhythmias with a malignant potential for resistance to conventional anti-arrhythmia medication].
    Câmpeanu A; Rădoi M; Serban-Pârâu G; Pleşca O; Nuţă M; Teodorescu V; Titirigă M
    Med Interna; 1993; 45(1-2):35-41. PubMed ID: 8081689
    [No Abstract]   [Full Text] [Related]  

  • 31. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients.
    Cerqueira PM; Cesarino EJ; Mateus FH; Mere Y; Santos SR; Lanchote VL
    Chirality; 1999; 11(7):591-7. PubMed ID: 10423287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration dependent stereoselectivity of propafenone N-depropylation metabolism with human hepatic recombinant CYP1A2.
    Zhou Q; Yao TW; Yu YN; Zeng S
    Pharmazie; 2003 Sep; 58(9):651-3. PubMed ID: 14531463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
    McAleer SD; Foondun AS; Feely M; Chrystyn H
    Chirality; 1997; 9(1):13-6. PubMed ID: 9094197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation].
    Romano S; Fattore L; Toscano G; Corsini F; Coppo A; Catanzaro M; Romano A; Martone A; Caccavale F; Iodice E; Di Maggio O; Corsini G
    Ital Heart J Suppl; 2001 Jan; 2(1):41-5. PubMed ID: 11216083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propafenone monitoring in patients with refractory ventricular arrhythmias.
    Arranz Peña MI; Moro C
    J Pharm Biomed Anal; 1989; 7(12):1915-8. PubMed ID: 2490583
    [No Abstract]   [Full Text] [Related]  

  • 38. Food increases the bioavailability of propafenone.
    Axelson JE; Chan GL; Kirsten EB; Mason WD; Lanman RC; Kerr CR
    Br J Clin Pharmacol; 1987 Jun; 23(6):735-41. PubMed ID: 3606933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselectivity in the metabolism of mexiletine by conjugation in female patients with the arrhythmic form of chronic Chagas' heart disease.
    Lanchote VL; Cesarino EJ; Santos VJ; Mere Júnior Y; Santos SR
    Chirality; 1999; 11(1):29-32. PubMed ID: 9914650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzyme induction in the elderly: effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone.
    Dilger K; Hofmann U; Klotz U
    Clin Pharmacol Ther; 2000 May; 67(5):512-20. PubMed ID: 10824630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.